DT Capital-Backed Tiansheng Pharma Completes IPO With $986M Valuation

Login to View

Tiansheng Pharmaceutical Group Co., Ltd., a Chinese drug maker backed by local private equity firms DT Capital Partners and Leading Capital, has completed an initial public offering on the Shenzhen Stock Exchange today.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in